Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio
Jilin Aodong Pharmaceutical Group Co Ltd cash flow-to-debt ratio. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥112.12 Million could theoretically repay 0% of its total liabilities (CN¥3.76 Billion) in one year. Check Jilin Aodong Pharmaceutical Group Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Cash flow-to-debt ratio of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. Historical debt coverage capacity for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Check Jilin Aodong Pharmaceutical Group Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Jilin Aodong Pharmaceutical Group Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 000623 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥272.26 Million | CN¥3.53 Billion | ▲ +382.2% |
| 2024 | 0.02x | CN¥59.48 Million | CN¥3.72 Billion | ▲ +12.0% |
| 2023 | 0.01x | CN¥68.06 Million | CN¥4.77 Billion | ▼ -83.7% |
| 2022 | 0.09x | CN¥423.86 Million | CN¥4.84 Billion | ▲ +8.5% |
| 2021 | 0.08x | CN¥324.85 Million | CN¥4.03 Billion | ▼ -19.9% |
| 2020 | 0.10x | CN¥390.41 Million | CN¥3.88 Billion | ▼ -10.9% |
| 2019 | 0.11x | CN¥379.46 Million | CN¥3.36 Billion | ▲ +11.0% |
| 2018 | 0.10x | CN¥347.64 Million | CN¥3.41 Billion | ▼ -47.7% |
| 2017 | 0.19x | CN¥256.49 Million | CN¥1.32 Billion | ▼ -14.5% |
| 2016 | 0.23x | CN¥333.81 Million | CN¥1.47 Billion | ▲ +32.0% |
| 2015 | 0.17x | CN¥388.03 Million | CN¥2.25 Billion | ▼ -33.7% |
| 2014 | 0.26x | CN¥288.83 Million | CN¥1.11 Billion | ▲ +30.0% |
| 2013 | 0.20x | CN¥201.22 Million | CN¥1.01 Billion | ▼ -11.3% |
| 2012 | 0.23x | CN¥272.40 Million | CN¥1.21 Billion | ▲ +105.3% |
| 2011 | 0.11x | CN¥108.30 Million | CN¥985.86 Million | ▼ -58.9% |
| 2010 | 0.27x | CN¥174.22 Million | CN¥652.43 Million | ▼ -24.6% |
| 2009 | 0.35x | CN¥213.03 Million | CN¥601.83 Million | ▼ -4.4% |
| 2008 | 0.37x | CN¥235.03 Million | CN¥634.74 Million | ▼ -28.3% |
| 2007 | 0.52x | CN¥384.69 Million | CN¥744.94 Million | ▲ +159.4% |
| 2006 | 0.20x | CN¥187.99 Million | CN¥944.28 Million | ▲ +21.3% |
| 2005 | 0.16x | CN¥136.26 Million | CN¥829.84 Million | ▼ -33.1% |
| 2004 | 0.25x | CN¥218.53 Million | CN¥890.13 Million | ▼ -0.2% |
| 2003 | 0.25x | CN¥147.65 Million | CN¥600.19 Million | ▲ +3379.2% |
| 2002 | -0.01x | CN¥-4.58 Million | CN¥609.94 Million | ▼ -102.8% |
| 2001 | 0.27x | CN¥138.76 Million | CN¥512.58 Million | ▲ +14.3% |
| 2000 | 0.24x | CN¥77.04 Million | CN¥325.23 Million | ▼ -0.1% |
| 1999 | 0.24x | CN¥110.18 Million | CN¥464.78 Million | ▲ +263.0% |
| 1998 | -0.15x | CN¥-30.90 Million | CN¥212.43 Million | — |